Discontinued — last reported Q3 '25
Non-Current Assets
Intangibles (Net)
Biogen Intangibles (Net) decreased by 1.7% to $7.25B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.7%, from $7.78B to $7.25B. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows an upward trend with a 26.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ3 2025
How to read this metric
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
Detailed definition
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Peer comparison
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
Metric ID:
intangible_assets_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.39B | $2.29B | $1.48B | $2.15B | $2.08B | $2.01B | $1.79B | $1.81B | $1.78B | $7.34B | $8.36B | $8.08B | $8.03B | $7.96B | $9.69B | $7.78B | $7.66B | $7.53B | $7.38B | $7.25B |
| QoQ Change | — | -4.1% | -35.4% | +45.6% | -3.5% | -3.2% | -11.1% | +1.5% | -2.0% | +313.5% | +13.9% | -3.4% | -0.6% | -0.9% | +21.8% | -19.7% | -1.5% | -1.8% | -2.0% | -1.7% |
| YoY Change | — | — | — | — | -13.0% | -12.2% | +20.9% | -15.7% | -14.4% | +265.6% | +368.2% | +345.6% | +352.0% | +8.4% | +15.9% | -3.7% | -4.5% | -5.4% | -23.9% | -6.7% |
Range$1.48B – $9.69B
CAGR+26.4%
Avg YoY Growth+79.8%
Median YoY Growth-4.1%
Current Streak5 quarters decline
Intangibles (Net) at Other Companies
Frequently Asked Questions
- What is Biogen's intangibles (net)?
- Biogen (BIIB) reported intangibles (net) of $7.25B in Q1 2026.
- How has Biogen's intangibles (net) changed year-over-year?
- Biogen's intangibles (net) decreased by 6.7% year-over-year, from $7.78B to $7.25B.
- What is the long-term trend for Biogen's intangibles (net)?
- Over 5 years (2020 to 2025), Biogen's intangibles (net) has grown at a 26.7% compound annual growth rate (CAGR), from $2.26B to $7.38B.
- What does intangibles (net) mean?
- The value of non-physical assets like patents and brands after accounting for amortization.